Related references
Note: Only part of the references are listed.Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy
Niccolo Maurizi et al.
CIRCULATION (2019)
Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study
Seshadri Balaji et al.
HEART RHYTHM (2019)
Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives Evidence for a Change in Paradigm
Gabrielle Norrish et al.
CIRCULATION (2019)
Genetic characterization and genotype-phenotype associations in a large cohort of patients with hypertrophic cardiomyopathy - An ancillary study of the Portuguese registry of hypertrophic cardiomyopathy
Luis Rocha Lopes et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
Carolyn Y. Ho et al.
CIRCULATION (2018)
Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy
J. Mathew et al.
CLINICAL GENETICS (2018)
Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals
Farbod Sedaghat-Hamedani et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
Penetrance of Hypertrophic Cardiomyopathy in Children Who Are Mutation Positive
Alexa M. C. Vermeer et al.
JOURNAL OF PEDIATRICS (2017)
Penetrance of Hypertrophic Cardiomyopathy in Children and Adolescents A 12-Year Follow-up Study of Clinical Screening and Predictive Genetic Testing
Morten K. Jensen et al.
CIRCULATION (2013)
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Bernard J. Gersh et al.
CIRCULATION (2011)
Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy
Imke Christiaans et al.
EUROPEAN HEART JOURNAL (2011)
Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy
Belinda Gray et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Predictive Genetic Testing for Cardiovascular Diseases: Impact on Carrier Children
Tineke M. Meulenkamp et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Health-dated quality of life of children with a positive carrier status for inherited cardiovascular diseases
Ellen M. A. Smets et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrest
Juergen Graf et al.
CRITICAL CARE (2008)
Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy
John J. You et al.
AMERICAN HEART JOURNAL (2007)
Share Paper
